Mon, October 8, 2012
Fri, October 5, 2012

Evan Seigerman Maintained (BIIB) at Buy with Increased Target to $175 on, Oct 8th, 2012

Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $165 to $175 on, Oct 8th, 2012.

Evan has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Evan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, October 4th, 2012


These are the ratings of the 3 analyists that currently disagree with Evan


  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, July 25th, 2012
  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012